Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland-Reference-Cited by-同舟云学术

Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland

Published:2013-12-18 Issue:1 Volume:135 Page:204-213
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Salo Heini¹,Nieminen Pekka²,Kilpi Terhi¹,Auranen Kari¹,Leino Tuija¹,Vänskä Simopekka¹³,Tiihonen Petri¹,Lehtinen Matti³,Anttila Ahti⁴

Affiliation:

1. Department of Vaccination and Immune Protection; National Institute for Health and Welfare (THL); Helsinki Finland

2. Department of Obstetrics and Gynecology; Helsinki University Central Hospital; Espoo Finland

3. School of Health Sciences; University of Tampere; Tampere Finland

4. Mass Screening Registry, Finnish Cancer Registry; Helsinki Finland

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence;Anttila;Int J Cancer,1999

2. Mass screenings/Cervical cancer screening. Finnish Cancer Registry 2012 http://www.cancer.fi/syoparekisteri/en/mass-screening-registry/statistics/cervical_cancer_screening/

3. Cervical cancer screening programmes and policies in 18 European countries;Anttila;Br J Cancer,2004

4. Gynekologisten irtosolunäytteiden määrät ja raportointitavat Suomessa;Monto;Suomen Lääkärilehti,2005

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scientific approaches toward improving cervical cancer elimination strategies;International Journal of Cancer;2024-01-09

3. EuroMed Cancer Network contributions to eliminating cervical cancer in low- and middle-income Mediterranean countries;Eastern Mediterranean Health Journal;2023-11-30

4. Effectiveness of Cervical Testing in and outside a Screening Program—A Case-Control Study;Cancers;2022-10-23

5. Alternative cytology triage strategies for primary HPV screening;Gynecologic Oncology;2022-10